Book Building - SME
₹ - cr
₹ 0
-
₹ -
NSE - SME
-
-
-
Initial public offer of upto 30,00,000 equity shares of face value of Rs. 10/- each (the equity shares) of Accretion Pharmaceuticals Limited (the company or accretion or the issuer) at an issue price of Rs. [*] per equity share for cash, aggregating up to Rs. [*] crores (public issue) out of which [*] equity shares of face value of Rs. 10 each, at an issue price of Rs. [*] per equity share for cash, aggregating Rs. [*] crores will be reserved for subscription by the market maker to the issue (the market maker reservation portion). The public issue less market maker reservation portion i.e., issue of [*] equity shares of face value of Rs. 10 each, at an issue price of Rs. [*] per equity share for cash, aggregating upto Rs. [*] crores is herein after referred to as the net issue. The public issue and net issue will constitute [*]% and [*]% respectively of the post-issue paid-up equity share capital of our company. The price band and the minimum bid lot will be decided by the company.
Capital expenditure towards purchase of new equipment/machineries, etc. Capital expenditure towards upgradation of existing mfg facility. Expenditure in connection with product registration in overseas market. Repayment/prepayment of certain borrowings availed by the company. Funding working capital requiremnts. General corporate purposes.
Accretion Pharmaceuticals Ltd, Karvy Selenium Tow-B, 31&32 Financial Dist, Nanakramguda, Hyderabad-500032
Phone - 91-40-67162222
Fax - 91-40-23001153/23420814
Email - care@accretionpharma.com
Website - http://www.accretionpharma.com